P. Kostakis

The acute and residual effects of escalating, analgesic-range doses of ketamine on driving performance: A simulator study

L. Downey, C. Stough, Y. Shehabi, 2018, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Isolation of a Human Homolog of Osteoclast Inhibitory Lectin That Inhibits the Formation and Function of Osteoclasts

W. McKinstry, A. Zannettino, M. Gillespie, 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Osteoprotegerin (OPG) is localized to the Weibel‐Palade bodies of human vascular endothelial cells and is physically associated with von Willebrand factor

A. Zannettino, L. To, J. Gamble, 2005, Journal of cellular physiology.

Receptor activator of nuclear factor-kappaB ligand expression by human myeloma cells mediates osteoclast formation in vitro and correlates with bone destruction in vivo.

L. To, A. Zannettino, D. Findlay, 2003, Cancer research.

Long-term imatinib therapy promotes bone formation in CML patients.

S. Fitter, B. Vernon‐roberts, L. To, 2008, Blood.

Accuracy of the Securetec DrugWipe 6s Ketamine device in detecting acute and residual salivary ketamine following a stepwise intravenous treatment protocol

L. Downey, C. Stough, Y. Shehabi, 2020 .

Human trabecular bone‐derived osteoblasts support human osteoclast formation in vitro in a defined, serum‐free medium

A. Zannettino, D. Findlay, G. Atkins, 2005, Journal of cellular physiology.

RANK Expression as a Cell Surface Marker of Human Osteoclast Precursors in Peripheral Blood, Bone Marrow, and Giant Cell Tumors of Bone

A. Evdokiou, A. Zannettino, Gerald J Atkins, 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

RANKL Expression Is Related to the Differentiation State of Human Osteoblasts

A. Evdokiou, S. Gronthos, A. Zannettino, 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Neurocognitive and behavioural performance of healthy volunteers receiving an increasing analgesic-range infusion of ketamine

L. Downey, Y. Shehabi, A. Hayley, 2018, Psychopharmacology.

Neurocognitive and behavioural performance of healthy volunteers receiving an increasing analgesic-range infusion of ketamine

L. Downey, Y. Shehabi, A. Hayley, 2018, Psychopharmacology.

Receptor activator of nuclear factor-kappaB ligand expression by human myeloma cells mediates osteoclast formation in vitro and correlates with bone destruction in vivo.

L. To, A. Zannettino, D. Findlay, 2003, Cancer research.